The Association Between Core Temperature and Health
Launched by SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY ,CHINESE ACADEMY OF SCIENCES · May 21, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether drinking cold water can help improve body composition and potentially extend healthy lifespan in older adults in China. The researchers want to find out if drinking very cold water (4°C) can reduce body fat and contribute to a longer, healthier life compared to drinking water at room temperature (37°C). Participants will drink either cold or room temperature water four times a day for six months and will have regular health checkups to monitor their progress.
To be eligible for this study, participants need to be between 50 and 65 years old, in good health without major medical conditions, and living in Shenzhen during the study. They should not have had any surgery in the last six months or significant weight changes recently. This trial is not currently recruiting participants, but it’s important for interested individuals to know they won't be able to join if they are on long-term medication, pregnant, or have certain health issues. Overall, this study aims to explore a simple lifestyle change to promote better health in older adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged between 50 and 65 years old (including 50 and 65)
- • No surgery in the past 6 months
- • Healthy (No metabolic diseases, cardiovascular diseases, lung diseases (COPD, asthma, et al.), endocrine diseases and gastrointestinal diseases)
- • Based in Shenzhen during the whole study period
- • No significant change on body weight in the past 3 months
- Exclusion Criteria:
- • Those who need to take medication for a long term (including diet pills)
- • On a diet
- • Disabled
- • Females who are trying to get pregnant, pregnant, or breastfeeding
- • Presence of a metal implant in the body (e.g. pacemaker)
- • Those with claustrophobia
- • Those with blood phobia, pathological hypotension or hypertension
- • Those who are in other intervention studies
About Shenzhen Institutes Of Advanced Technology ,Chinese Academy Of Sciences
The Shenzhen Institutes of Advanced Technology (SIAT), part of the Chinese Academy of Sciences, is a leading research institution dedicated to advancing scientific knowledge and technology across various fields, including biomedical research. SIAT is committed to fostering innovation through interdisciplinary collaboration and state-of-the-art facilities, focusing on the translation of research into practical applications. With a strong emphasis on clinical trials and regulatory compliance, SIAT aims to contribute to the global healthcare landscape by developing novel therapies and solutions that address pressing medical challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shenzhen, Guangdong, China
Patients applied
Trial Officials
John R Speakman, PhD
Study Chair
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported